0001062993-14-002497.txt : 20140501 0001062993-14-002497.hdr.sgml : 20140501 20140501101241 ACCESSION NUMBER: 0001062993-14-002497 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140501 DATE AS OF CHANGE: 20140501 EFFECTIVENESS DATE: 20140501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN MEDICAL INC CENTRAL INDEX KEY: 0000840551 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-216607 FILM NUMBER: 14802469 BUSINESS ADDRESS: STREET 1: 170 UNIVERSITY AVENUE CITY: TORONTO STATE: A6 ZIP: M5H 3B3 BUSINESS PHONE: 416-548-8522 MAIL ADDRESS: STREET 1: 170 UNIVERSITY AVENUE CITY: TORONTO STATE: A6 ZIP: M5H 3B3 D 1 primary_doc.xml X0707 D LIVE 0000840551 TITAN MEDICAL INC 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 416-548-7522 ONTARIO, CANADA None None Corporation true John T. Hargrove 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 Executive Officer Director Reiza Rayman 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 Executive Officer Director Stephen D. Randall 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 Executive Officer John R. Valvo 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 Executive Officer Joseph Talarico 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 Executive Officer John E. Barker 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 Director Martin C. Bernholtz 170 University Avenue Suite 1000 Toronto A6 ONTARIO, CANADA M5H 3B3 Director Other Decline to Disclose 06b false 2014-04-23 false true true true true Unit = 1 common share and 1 common share purchase warrant false 0 Dundee Securities Ltd. None Dundee Securities Inc. 39759 1 Adelaide Street East Suite 2000 Toronto A6 ONTARIO, CANADA M5C 2V9 MA MASSACHUSETTS false 2930926 1269061 1661865 Aggregate offering includes amount that may be received by Issuer upon exercise of warrants. Each warrant may be exercised for 1 common share at CDN$2.75 per share for 3 years from the date of closing. false 1 76144 0 In addition to the cash commission, the Agent may receive up to 40,001 warrants. Each warrant may be exercised for 1 common share at CDN$2.75 per share for 3 years from the date of closing. 0 false TITAN MEDICAL INC /s/ Stephen D. Randall Stephen D. Randall Chief Financial Officer 2014-04-30